OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
XPO1 inhibition sensitises CLL cells to NK cell mediated cytotoxicity and overcomes HLA-E expression
Jack G. Fisher, Amber D. P. Doyle, Lara V. Graham, et al.
Leukemia (2023) Vol. 37, Iss. 10, pp. 2036-2049
Open Access | Times Cited: 9
Jack G. Fisher, Amber D. P. Doyle, Lara V. Graham, et al.
Leukemia (2023) Vol. 37, Iss. 10, pp. 2036-2049
Open Access | Times Cited: 9
Showing 9 citing articles:
Exploring treatment options in cancer: Tumor treatment strategies
Beilei Liu, Hongyu Zhou, Licheng Tan, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 155
Beilei Liu, Hongyu Zhou, Licheng Tan, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 155
Harnessing natural killer cell effector function against cancer
Matthew D. Blunt, Salim I. Khakoo
Immunotherapy Advances (2023) Vol. 4, Iss. 1
Open Access | Times Cited: 9
Matthew D. Blunt, Salim I. Khakoo
Immunotherapy Advances (2023) Vol. 4, Iss. 1
Open Access | Times Cited: 9
NK Cells in the Lymph Nodes and Their Role in Anti-Tumour Immunity
Lara V. Graham, Salim I. Khakoo, Matthew D. Blunt
Biomedicines (2024) Vol. 12, Iss. 8, pp. 1667-1667
Open Access | Times Cited: 1
Lara V. Graham, Salim I. Khakoo, Matthew D. Blunt
Biomedicines (2024) Vol. 12, Iss. 8, pp. 1667-1667
Open Access | Times Cited: 1
Exploring the prognostic value of T follicular helper cell levels in chronic lymphocytic leukemia
Rui Zhang, Sha Guo, Jianhua Qu
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 1
Rui Zhang, Sha Guo, Jianhua Qu
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 1
Insights into genetic aberrations and signalling pathway interactions in chronic lymphocytic leukemia: from pathogenesis to treatment strategies
Anna Sobczyńska-Konefał, Monika Jasek, Lidia Karabon, et al.
Biomarker Research (2024) Vol. 12, Iss. 1
Open Access | Times Cited: 1
Anna Sobczyńska-Konefał, Monika Jasek, Lidia Karabon, et al.
Biomarker Research (2024) Vol. 12, Iss. 1
Open Access | Times Cited: 1
A high affinity monoclonal antibody against HLA-E-VL9 enhances natural killer cell anti-tumor killing
Joyce K. Hwang, Daniel J. Marston, Daniel Wrapp, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Closed Access
Joyce K. Hwang, Daniel J. Marston, Daniel Wrapp, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Closed Access
Strategies to disrupt NKG2A:HLA-E interactions for improved anti-cancer immunity
Jack G. Fisher, Lara V. Graham, Matthew D. Blunt
Oncotarget (2024) Vol. 15, Iss. 1, pp. 501-503
Open Access
Jack G. Fisher, Lara V. Graham, Matthew D. Blunt
Oncotarget (2024) Vol. 15, Iss. 1, pp. 501-503
Open Access
Natural Killer Cells in Anti-Tumour Immunity
Lara V. Graham, Matthew D. Blunt
Elsevier eBooks (2024)
Closed Access
Lara V. Graham, Matthew D. Blunt
Elsevier eBooks (2024)
Closed Access
Deciphering the regulatory mechanisms and biological implications of ARID1A missense mutations in cancer
Fang Liu, Jun Ying, Kai Yang, et al.
Cell Reports (2024) Vol. 43, Iss. 11, pp. 114916-114916
Open Access
Fang Liu, Jun Ying, Kai Yang, et al.
Cell Reports (2024) Vol. 43, Iss. 11, pp. 114916-114916
Open Access
